Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 78678

10 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 10, 2017
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
SSM Health Care St. Louis DBA SSM St. Clare Health Center

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

10 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 10

Fentanyl 10 mcg in 0.9% Sodium Chloride 1 mL, 1 mL Vial, Concentration: 10 mcg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88890-9010-81

D-0136-2018
Recall number
D-0136-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot: 170614-006, exp 9/12/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 2 of 10

Amiodarone 900 mg in dextrose 5% 500 mL, 500 mL bag, Concentration: 1.8 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88890-0333-01

D-0137-2018
Recall number
D-0137-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot: 170711-005, 10/09/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 3 of 10

Fentanyl 2 mcg/mL and ropivacaine 0.2% in 0.9% Sodium Chloride 150 mL, 150 mL bag, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88883-4272-01

D-0138-2018
Recall number
D-0138-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot, exp: 170621-008, 09/19/2017; 170703-002, 10/01/2017; 170711-031, 10/09/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 4 of 10

HYDROmorphone 10 mg in 0.9% Sodium Chloride 50 mL PCA, 50 mL Cartridge, Concentration: 0.2 mg/mL., This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88883-0600-01

D-0139-2018
Recall number
D-0139-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot, exp: 170615-004, 9/13/2017; 170720-009, 10/18/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 5 of 10

Morphine 50 mg in 0.9% Sodium Chloride 5 mL PCA, 50 mL Cartridge, Concentration: 1 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88887-6795-01

D-0140-2018
Recall number
D-0140-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot, exp: 170627-012, 9/25/2017; 170629-019, 9/27/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 6 of 10

Neostigmine Methylsulfate 5 mg/5 mL, 5 mL Syringe, Concentration: 1 mg/mL. This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO --- NDC: 88890-0329-01

D-0141-2018
Recall number
D-0141-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot: 170705-002, 10/03/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 7 of 10

Norepinephrine 8 mg in dextrose 5% 250 mL, 250mL IV Bag, Concentration: 0.032 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, , Fenton, MO --- NDC: 88890-0334-01

D-0142-2018
Recall number
D-0142-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot, exp: 170614-007, 9/12/2017; 170628-001, 9/26/2017; 170703-017, 10/1/2017; 170706-009, 10/4/2017; 170719-007, 10/17/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 8 of 10

Oxytocin 30 units in 0.9% Sodium Chloride 500 mL, 500 mL IV Bag, Concentration: 0.06 units/mL. This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO --- NDC: 88890-0903-01

D-0143-2018
Recall number
D-0143-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot, exp: 170619-011, 9/17/2017; 170707-007, 10/5/2017; 170713-009, 10/11/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 9 of 10

Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mL, 10 mL syringe, Concentration: 100 mcg/mL. This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO --- NDC: 88890-0104-01

D-0144-2018
Recall number
D-0144-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot, exp: 170622-007, 9/20/2017; 170710-007, 10/8/2017

Distribution pattern

SSM Health entities in the state of MO only

drug · product 10 of 10

Succinylcholine chloride 100 mg in 5 mL syringe, Concentration: 20 mg/mL. This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO --- NDC: 88890-7536-01

D-0145-2018
Recall number
D-0145-2018
Initiated
August 10, 2017
Classification
Class II
Status
Terminated
Quantity
N/A

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
Microbial growth
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Code information

Lot, exp: 170620-005, 9/18/2017; 170626-003, 9/24/2017

Distribution pattern

SSM Health entities in the state of MO only